Literature DB >> 29223638

PD-L1 Expression in a Non-Small Cell Lung Cancer Specimen Obtained by EBUS-TBNA.

Sebastián Fernandez-Bussy1, Yumay Pires2, Gonzalo Labarca3, Macarena R Vial4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29223638     DOI： 10.1016/j.arbres.2017.10.008

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  7 in total

1.  Immune phenotypes in lung cancer patients with COPD: potential implications for immunotherapy.

Authors:  Roberto Chalela; Joaquim Gea; Esther Barreiro
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  EBUS in optimizing non-small cell lung cancer diagnosis and treatment.

Authors:  Antonia Haranguş; Ioana Berindan-Neagoe; Lăcrămioara Toma; Ioan Şimon; Ovidiu Pop; Mărioara Şimon
Journal:  Med Pharm Rep       Date:  2021-04-29

3.  Immunotherapy with Monoclonal Antibodies in Lung Cancer of Mice: Oxidative Stress and Other Biological Events.

Authors:  Jun Tang; Daniel Ramis-Cabrer; Xuejie Wang; Esther Barreiro
Journal:  Cancers (Basel)       Date:  2019-09-04       Impact factor: 6.639

Review 4.  PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature.

Authors:  Mohammed S I Mansour; Kajsa Ericson Lindquist; Tomas Seidal; Ulrich Mager; Rikard Mohlin; Lena Tran; Kim Hejny; Benjamin Holmgren; Despoina Violidaki; Katalin Dobra; Annika Dejmek; Maria Planck; Hans Brunnström
Journal:  Acta Cytol       Date:  2021-07-07       Impact factor: 2.319

Review 5.  Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?

Authors:  Pattraporn Tajarernmuang; Linda Ofiara; Stéphane Beaudoin; Anne V Gonzalez
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

Review 6.  The role of EBUS-TBNA in lung cancer restaging and mutation analysis.

Authors:  Piergiorgio Muriana; Francesca Rossetti
Journal:  Mediastinum       Date:  2020-09-30

7.  Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.

Authors:  Marija Karadzovska-Kotevska; Hans Brunnström; Jaroslaw Kosieradzki; Lars Ek; Christel Estberg; Johan Staaf; Stefan Barath; Maria Planck
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.